… of coronary artery disease (CAD), however the impact of anti-inflammatory therapies to reduce
… the hypothesis that anti-inflammatory approaches improve impaired coronary endothelial …

… by which statins reduce cardiovascular risk, especially the anti-inflammatory effect. Most likely,
… -lowering therapy on the coronary endothelium in patients with coronary artery disease. N …

… antagonist that acts as pleiotropic cardiac protective hormone. This study investigated the
association between CST and coronary artery disease (CAD) and the underlying mechanisms. …

… whether non-aspirin non-steroidal anti-inflammatory drug (NSAID) use is associated with
increased cardiovascular risks in patients with non-obstructive coronary artery disease (CAD). …

… This study aimed to declare the underlying pharmacological mechanism of anti-inflammatory
activity of TMYX in the treatment of CHD via clinical trial, microarray study, bioinformatics …

… no standard treatment guidelines specified for CAE. Anti-inflammatory and endothelium-…
to improve the symptoms in patients with coronary artery disease [11]. Rosuvastatin is a …

… Statin has been used for anti-inflammatory treatment for CAD, although it is also commonly
used for antiatherosclerosis. In this study, we revealed that atorvastatin decreased the …

… We can draw several conclusions from the results of this trial, which has indeed set a precedent
for anti-inflammatory therapy in secondary prevention of CAD in the absence of lowering …

… In parallel to a reduction in CRP, aspirin treatment with 300 mg per day also reduces the …
finding which implies a direct link between the anti-inflammatory effect of this COX-inhibitor with …

… to their pleiotropic, anti-inflammatory effects. The Justification … coronary artery disease to
moderate (40 mg of pravastatin per day) vs. intensive (80 mg of atorvastatin per day) treatment…